Specialty: Cardiovascular disease, Primary sub-specialty: Arrhythmia Circulatory System Arrhythmia
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. End Stage Renal Failure (ESRF) 2. Received regular haemodialysis for a minimum of 90 days prior to study entry and is expected to continue with haemodialysis indefinitely or until renal transplant 3. At least 18 years of age 4. Willing and able to comply with investigational plan and willing to remain available for follow-up through to study closure 5. Willing and able to sign/date the study informed consent
Exclusion criteria
Exclusion criteria: 1. Myocardial infarction in preceding 40 days prior to enrolment 2. Already implanted with a cardiac device, such as pacemaker, defibrillator or implantable loop recorder (ILR) 3. Life expectancy less than one year in the opinion of an Investigator 4. Enrolled in another research study 5. Expected to have poor compliance with the study protocol 6. Pregnancy or breastfeeding 7. Haemodialysis via leftsided tunnelled central venous catheter 8. Expected to require a thoracic magnetic resonance image (MRI)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Sudden cardiac death (SCD) is measured using continuous ECG data downloaded from the ILR device. In addition to clinical information and post mortem examination where performed. 2. Implantation of pacing device is measured by reporting the number of pacemakers or defibrillators that were implanted during the course of the study. | — |
Secondary
| Measure | Time frame |
|---|---|
| Development of significant arrhythmia necessitating medical intervention is measured using continuous ECG data from the ILR device. | — |
Countries
England, United Kingdom